PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0025PA260Radiopharmaceuticals requirement IS necessary — Sofie Co

Sofie Co holds $30.8M across 107 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Mrc0 West

Awarding office

Sofie Co

Recipient

Sep 30, 2026

PoP end

$188K

Obligated

$188K

Potential

325412

NAICS

6505

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Sofie Co — $90

Contract facts

NONE

Contract numberW81K0025PA260

AgencyW40m Mrc0 West

Awarding officeW40m Mrc0 West

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentSofie Co

CAGE09QR8

UEIJV1AHJHGUGG3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Place of performanceSAN ANTONIO TX

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startOct 1, 2025

PoP end (current)Sep 30, 2026

Obligated$188K

Current value$188K

Potential value$188K

RADIOPHARMACEUTICALS REQUIREMENT IS NECESSARY TO SUPPORT THE DEPARTMENT OF RADIOLOGY, NUCLEAR MEDICINE CLINIC. is a federal NONE award for W40m Mrc0 West held by Sofie Co. Estimated value $188K ($188K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: SAN ANTONIO TX.

RADIOPHARMACEUTICALS REQUIREMENT IS NECESSARY TO SUPPORT THE DEPARTMENT OF RADIOLOGY, NUCLEAR MEDICINE CLINIC.

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Sofie Co — $30.8M obligated across 107 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($30.8M) · all agencies

Department of Veterans Affairs (VA)$27.8M · 90%Department of Defense (DOD)$2.9M · 9%

Open full company profile →

Related awards

Same incumbent

36C25525N0412

F18 PROSTATE-SPECIFIC MEMBRANE AGENT (PSMA) - OPTION YEAR 3

$217K

Aug 31, 2026

36C25026N0023

EXERCISING THE ORDERING PERIOD 5

$2.0M

Sep 30, 2026

36C25025F0011

ORDERING PERIOD 4 FOR OY25

$1.6M

Sep 30, 2026

36C25625N0859

PYLARIFY PIFLUFOLASTAT F18

$1.2M

Sep 30, 2026

36C25023N0051

TO EXERCISE ORDERING PERIOD 2. THE ADDITION OF CU 64 DOSES TO RADIOPHARM PET RX

$872K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0025PA260?

W81K0025PA260 (Radiopharmaceuticals requirement IS necessary) is a W40m Mrc0 West award with a potential value of $188K, currently held by Sofie Co. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W81K0025PA260?

W40m Mrc0 West awarded W81K0025PA260 to Sofie Co (potential $188K).

Who is the incumbent on W81K0025PA260?

Sofie Co is the incumbent with $30.8M across 107 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Sofie Co’s W81K0025PA260 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action Dec 18, 2025